Ontology highlight
ABSTRACT:
SUBMITTER: Steigler A
PROVIDER: S-EPMC3540903 | biostudies-other | 2012
REPOSITORIES: biostudies-other
Steigler Allison A Denham James W JW Lamb David S DS Spry Nigel A NA Joseph David D Matthews John J Atkinson Chris C Turner Sandra S North John J Christie David D Tai Keen-Hun KH Wynne Chris C
Prostate cancer 20121224
Purpose. Survival following biochemical failure is highly variable. Using a randomized trial dataset, we sought to define a risk stratification scheme in men with locally advanced prostate cancer (LAPC). Methods. The TROG 96.01 trial randomized 802 men with LAPC to radiation ± neoadjuvant androgen suppression therapy (AST) between 1996 and 2000. Ten-year follow-up data was used to develop three-tier post-biochemical failure risk stratification schemes based on cutpoints of time to biochemical fa ...[more]